Dr. Richard M. Bayney President & Founder Domain Expertise - Project & Portfolio Management, Risk Analysis & Risk Management, Asset Valuation, Strategic Planning, Licensing & Business Development, Drug Discovery & Development 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Bayer Corp. and AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development Previous position - Vice President, Portfolio Management & Decision Analysis, Johnson & Johnson Pharmaceutical Research & Development 11 years building and leading departments in Strategic Planning, Decision Analysis, and Portfolio Management 2 years as International Project Manager for marketed cardiovascular drug 10 years in Molecular Biology research into gene expression of (a) hepatic drug detoxification systems and (b) amyloid precursor protein in Alzheimer’s Disease Faculty member at School of Arts & Sciences and School of Engineering, University of Pennsylvania lecturing in (a) Project Portfolio Management and (b) Decision Modeling Frequent speaker in ‘Portfolio & Resource Management, Risk Analysis & Risk Management, and Strategic Planning in Drug Development’ for Parexel/Barnett International, Global Benchmarking Group, Strategic Research Institute, Center For Business Intelligence, Phacilitate R&D Leaders’ Forum, Institute For International Research, Pharmaceutical Management Science Association, Product Development & Management Association, Tufts Center For The Study Of Drug Development, Med Ad News, Cambridge Healthtech Institute, EXL Pharma, Honeycomb Connect (PILS), and Decision Analysis Affinity Group Advisory Board Member to Cambridge Healthtech Institute M.Sc. and Ph.D. from University of London, MBA from Columbia University, and PMP from Project Management Institute